Clinical Trials on Pharmacokinetics Study in de Novo Kidney Transplantation in France
Total 7 results
-
Astellas Pharma IncCompletedDe Novo Kidney TransplantationBelgium, France, Netherlands, Spain, Sweden, Austria, Italy, Germany, United Kingdom, Hungary, Poland, Czech Republic
-
University Hospital, LimogesCompletedTransplantation | Pharmacokinetic | KidneyFrance
-
University Hospital, ToursRoche Pharma AGCompletedHumoral Rejection in Kidney TransplantationFrance
-
Hansa Biopharma ABRecruitingKidney Transplantation in Highly Sensitized PatientsGermany, Spain, Italy, France, Netherlands, Belgium, Austria, Czechia, Sweden, United Kingdom, Slovenia
-
Institut CurieNational Cancer Institute, France; Fondation ARCTerminatedAcute Myeloid Leukemia, in Relapse | Therapy-related Acute Myeloid Leukemia and Myelodysplastic Syndrome | de Novo Acute Myeloid Leukemia at DiagnosticFrance
-
University Hospital, Strasbourg, FranceRecruitingIgA Nephropathy Severity in Kidney TransplantationFrance
-
Brian JonasPharmacyclics LLC.CompletedChronic Myelomonocytic Leukemia | Previously Treated Myelodysplastic Syndrome | Secondary Myelodysplastic Syndrome | de Novo Myelodysplastic Syndrome | Refractory Anemia With Excess Blasts in TransformationUnited States